Oculogica, Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2013

Location

New York NY US

Primary Industry

Medical Devices & Equipment

About

Based in New York, US, and founded in 2013 by Uzma Samadani, Oculogica, Inc. specializes in concussion diagnosis and categorization, with the FDA-cleared technology that aids in the diagnosis of concussion without a pre-injury baseline test requirement. In May 2021, Oculogica, Inc. received USD 2 million of grant funding led by the US Army Medical Research and Material Command. Rosina Samandani is the CEO of the company. Oculogica, Inc. offers EyeBox, which is the FDA-cleared baseline-free aid in the diagnosis of concussion to help physicians objectively categorize concussion. This device provides a 4-minute test for ages between 5 to 67 and provides a Box Score to help physicians to determine the presence of a concussion. The company's product is used by various healthcare organizations, including the clinics of the President of the California Brain Injury Association, Midwest Orthopedics at Rush University, and others. Oculogica, Inc. will use the funding to develop wearable concussion diagnostics with pre-eminent partners.

Current Investors

Golden Seeds, US Army Medical Research and Material Command, Nebraska Angels

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Diagnostic Equipment

Website

www.oculogica.com

Verticals

HealthTech

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.